232 related articles for article (PubMed ID: 35864416)
1. Long non‑coding RNA PART1: dual role in cancer.
Ran R; Gong CY; Wang ZQ; Zhou WM; Zhang SB; Shi YQ; Ma CW; Zhang HH
Hum Cell; 2022 Sep; 35(5):1364-1374. PubMed ID: 35864416
[TBL] [Abstract][Full Text] [Related]
2. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis.
Zhao Y; Zhang Q; Liu H; Wang N; Zhang X; Yang S
Oncol Rep; 2021 Mar; 45(3):1118-1132. PubMed ID: 33432363
[TBL] [Abstract][Full Text] [Related]
3. Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA.
Kang M; Ren M; Li Y; Fu Y; Deng M; Li C
J Exp Clin Cancer Res; 2018 Jul; 37(1):171. PubMed ID: 30049286
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2.
Han H; Wang S; Meng J; Lyu G; Ding G; Hu Y; Wang L; Wu L; Yang W; Lv Y; Jia S; Zhang L; Ji J
Oncogene; 2020 Oct; 39(42):6513-6528. PubMed ID: 32901105
[TBL] [Abstract][Full Text] [Related]
5. LncRNA
Wang J; Han Y; Zhang T; Li J; Xu B
Front Biosci (Landmark Ed); 2023 Oct; 28(10):270. PubMed ID: 37919051
[TBL] [Abstract][Full Text] [Related]
6. The Role of Tumor-related LncRNA PART1 in Cancer.
Chen J; Meng E; Lin Y; Shen Y; Hu C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(40):4152-4159. PubMed ID: 34225608
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122.
Hu X; Zhang L; Tian J; Ma J
World J Surg Oncol; 2021 Apr; 19(1):122. PubMed ID: 33865422
[TBL] [Abstract][Full Text] [Related]
8. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
9. Role of SNHG16 in human cancer.
Gong CY; Tang R; Nan W; Zhou KS; Zhang HH
Clin Chim Acta; 2020 Apr; 503():175-180. PubMed ID: 31901482
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PART1 Stimulates the Development of Ovarian Cancer by Up-regulating RACGAP1 and RRM2.
Li H; Lei Y; Li S; Li F; Lei J
Reprod Sci; 2022 Aug; 29(8):2224-2235. PubMed ID: 35553409
[TBL] [Abstract][Full Text] [Related]
11. LncRNA PART1 promotes lung squamous cell carcinoma progression via miR-185-5p/Six1 axis.
Cao Y; Zhang R; Luo X; Yang Y
Hum Exp Toxicol; 2021 Jun; 40(6):960-976. PubMed ID: 33300377
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells.
Li FZ; Zang WQ
World J Gastroenterol; 2019 Nov; 25(42):6299-6310. PubMed ID: 31754291
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma.
Ma J; Xiao Y; Tian B; Chen S; Zhang B; Wu J; Wu Z; Li X; Tang J; Yang D; Zhou Y; Wang H; Su M; Wang W
J Cell Biochem; 2020 Feb; 121(2):1374-1387. PubMed ID: 31512786
[TBL] [Abstract][Full Text] [Related]
14. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
15. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
Yu Q; Du Y; Wang S; Zheng X
J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
[TBL] [Abstract][Full Text] [Related]
16. LncRNA PART1 modulates toll-like receptor pathways to influence cell proliferation and apoptosis in prostate cancer cells.
Sun M; Geng D; Li S; Chen Z; Zhao W
Biol Chem; 2018 Mar; 399(4):387-395. PubMed ID: 29261512
[TBL] [Abstract][Full Text] [Related]
17. LncRNA PART1 modulates chondrocyte proliferation, apoptosis, and extracellular matrix degradation in osteoarthritis via regulating miR-373-3p/SOX4 axis.
Zhu YJ; Jiang DM
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8175-8185. PubMed ID: 31646607
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Yao GL; Pan CF; Xu H; Wei K; Liu B; Zhai R; Chen YJ
Biomed Pharmacother; 2017 Apr; 88():778-785. PubMed ID: 28157654
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of PART1 Inhibits Proliferation and Differentiation of Hep3B Cells by Targeting hsa-miR-3529-3p/FOXC2 Axis.
Weng Z; Peng J; Wu W; Zhang C; Zhao J; Gao H
J Oncol; 2021; 2021():7792223. PubMed ID: 34484336
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1.
Duan Y; Jia Y; Wang J; Liu T; Cheng Z; Sang M; Lv W; Qin J; Liu L
Cell Death Dis; 2021 Jun; 12(6):587. PubMed ID: 34099633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]